As mentioned above, a large number of studies on the changes of plasma Aβ and Tau concentrations in patients with aMCI and early AD have confirmed that changes in plasma Aβ and Tau concentrations can reflect changes in brain Aβ and Tau concentrations to a certain extent. This evidence concerns the gene MAPT and Alzheimer disease.